In this single-centre , randomised , double blind , placebo-controlled trial , 31 patients with aSAH were randomised to IV-D 1.25 mg every 6h for 7days ( n = 16 ) or equiosmolar free water/5 % mannitol ( placebo ; n = 15 ) .